His lab is working on refining the alanine-scanning assay to a few vital residues that may properly distinguish between fibrils from neurodegenerative tauopathies. He envisions making use of this streamlined assay for postmortem neuropathological diagnosis, And perhaps for blood screening of tauopathies.With the La Biennale di Venezia Web page: “